Liquidia Corporation $LQDA Shares Bought by Sei Investments Co.

Sei Investments Co. increased its holdings in Liquidia Corporation (NASDAQ:LQDA) by 306.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 35,655 shares of the company’s stock after buying an additional 26,879 shares during the period. Sei Investments Co.’s holdings in Liquidia were worth $1,346,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Covestor Ltd raised its stake in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock worth $42,000 after acquiring an additional 359 shares during the period. PNC Financial Services Group Inc. grew its holdings in shares of Liquidia by 7.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after purchasing an additional 422 shares during the last quarter. Northwestern Mutual Wealth Management Co. bought a new position in shares of Liquidia during the fourth quarter valued at approximately $25,000. ProShare Advisors LLC raised its position in shares of Liquidia by 7.1% during the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after purchasing an additional 775 shares during the period. Finally, Alliancebernstein L.P. lifted its holdings in shares of Liquidia by 1.4% in the 3rd quarter. Alliancebernstein L.P. now owns 67,050 shares of the company’s stock worth $1,525,000 after purchasing an additional 900 shares during the last quarter. Institutional investors own 64.54% of the company’s stock.

Liquidia Stock Down 3.3%

LQDA opened at $88.05 on Wednesday. Liquidia Corporation has a 12 month low of $21.15 and a 12 month high of $93.61. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The stock has a market cap of $7.83 billion, a P/E ratio of 628.97 and a beta of 0.58. The stock’s 50 day moving average price is $77.76 and its 200 day moving average price is $54.51.

Liquidia (NASDAQ:LQDA) last announced its earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The firm had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. The company’s revenue was up 4187.1% compared to the same quarter last year. As a group, research analysts predict that Liquidia Corporation will post 3.02 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on LQDA shares. Royal Bank Of Canada set a $130.00 price objective on Liquidia in a research report on Friday, July 24th. Wall Street Zen lowered Liquidia from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 27th. BTIG Research raised their target price on Liquidia from $59.00 to $109.00 and gave the company a “buy” rating in a research note on Monday, June 22nd. Raymond James Financial reissued a “strong-buy” rating and set a $68.00 price target on shares of Liquidia in a report on Thursday, June 4th. Finally, HC Wainwright set a $36.00 price target on shares of Liquidia in a research report on Friday, July 24th. Three equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $86.18.

Insiders Place Their Bets

In related news, Director Stephen M. Bloch sold 242,269 shares of the company’s stock in a transaction dated Thursday, June 11th. The shares were sold at an average price of $70.43, for a total value of $17,063,005.67. Following the completion of the sale, the director owned 1,176,184 shares of the company’s stock, valued at $82,838,639.12. This represents a 17.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Paul B. Manning sold 200,000 shares of the stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $63.91, for a total transaction of $12,782,000.00. Following the completion of the transaction, the director owned 716,311 shares of the company’s stock, valued at $45,779,436.01. This represents a 21.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,781,861 shares of company stock worth $124,407,112 over the last three months. Corporate insiders own 25.60% of the company’s stock.

Liquidia Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).